FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreThe bipartisan U.S. House Task Force on Artificial Intelligence (AI) released its highly anticipated report on AI Dec. 17. The nonbinding report is intended to inform policymaking activities and priorities of the next Congress and covers a broad range of cross-cutting and sector-specific issues, including those related to the healthcare sector. The American College of Radiology® (ACR®) met with congressional offices and provided comments in May to inform the task force’s efforts.
In general, the task force supports leveraging and expanding the authorities of existing regulatory agencies within the specific sectors instead of creating a centralized AI agency. With regard to healthcare, the task force recommends:
For more information about ACR’s AI-related programs and initiatives, visit the ACR Data Science Institute website. For questions about AI oversight policy, contact Michael Peters, ACR Senior Director, Government Affairs.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more